Rab 30 Inhibitors
Rab30 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Rab30 protein, a member of the Rab family of small GTPases. These small GTPases are critical regulators of intracellular trafficking, membrane transport, and organelle dynamics. Rab30 is known to be involved in processes such as Golgi apparatus function and vesicle transport, playing a key role in maintaining cellular homeostasis. By inhibiting Rab30, these compounds interfere with its role in regulating membrane trafficking pathways, which can affect cellular organization and signaling. The design of Rab30 inhibitors is based on their ability to modulate the active GTP-bound state of Rab30 or disrupt its interactions with other effector proteins necessary for its cellular functions.
The development of Rab30 inhibitors requires a deep understanding of the structural features of Rab30, including its binding pockets and domains critical for GTP binding and hydrolysis. These inhibitors often contain molecular motifs that allow them to bind selectively to the active site or other regulatory domains of Rab30, thereby preventing its normal function. Structural analogs, competitive inhibitors, and small molecules capable of modulating Rab30 activity have been explored to provide specificity and efficacy in disrupting its function. These compounds are essential tools for understanding the role of Rab30 in cellular processes, including vesicle formation, trafficking, and the maintenance of organelle structure. Furthermore, studying Rab30 inhibitors helps elucidate the broader mechanisms of Rab GTPase regulation and the downstream cellular pathways they control, contributing to a detailed understanding of intracellular dynamics and protein trafficking.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lonafarnib | 193275-84-2 | sc-482730 sc-482730A | 5 mg 10 mg | $173.00 $234.00 | ||
Lonafarnib is a farnesyltransferase inhibitor. Since Rab-30undergoes post-translational lipid modifications like farnesylation, this compound could potentially prevent Rab-30 from associating with membranes, affecting its stability and expression. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
Tipifarnib is another farnesyltransferase inhibitor. It could inhibit Rab-30s membrane association by interfering with its farnesylation, potentially affecting its stability and subsequent expression. | ||||||
Farnesyl thiosalicylic acid | 162520-00-5 | sc-205322 sc-205322A | 1 mg 5 mg | $61.00 $82.00 | 15 | |
Salirasib disrupts the association between Ras and its membrane anchor. Though not directly targeting Rab-30, it might affect Rab-30 function if similar mechanisms exist between Ras and Rab GTPases. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $92.00 $256.00 | 5 | |
Zoledronic Acid inhibits farnesyl pyrophosphate synthase. By affecting the farnesylation pathway, it could alter Rab-30's lipid modification and membrane association. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A is an inhibitor of farnesyltransferase. It could potentially affect Rab-30's post-translational modification, influencing its localization and expression. | ||||||
GGTI 298 | 1217457-86-7 | sc-361184 sc-361184A | 1 mg 5 mg | $193.00 $838.00 | 2 | |
GGTI-298 inhibits geranylgeranyltransferase I. Though Rab-30 is more commonly farnesylated, if it undergoes geranylgeranylation, this compound could affect its function and expression. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 inhibits the activation of Rac1, another GTPase. If pathways overlap with Rab-30's, it could influence Rab-30's activation or expression indirectly. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $213.00 $889.00 | 12 | |
EHT 1864 is an inhibitor of Rac family GTPases. It might affect Rab-30 indirectly if Rac and Rab proteins have overlapping regulatory mechanisms. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42 GTPase. If Cdc42 has any indirect regulatory mechanism with Rab-30, this compound might affect Rab-30's function or expression. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 inhibits cytohesins, which are ARF GTPase exchange factors. If there's crosstalk between ARF and Rab pathways, Rab-30 expression could be influenced. | ||||||